The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlpha Real Regulatory News (ARTL)

Share Price Information for Alpha Real (ARTL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 137.50
Bid: 130.00
Ask: 145.00
Change: 0.00 (0.00%)
Spread: 15.00 (11.538%)
Open: 137.50
High: 137.50
Low: 137.50
Prev. Close: 137.50
ARTL Live PriceLast checked at -
Alpha Real is an Investment Trust

To seek high total returns through focusing on high-yielding property, real estate, infrastructure, asset backed debt and equity investments in Western Europe.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition

19 Oct 2012 13:35

RNS Number : 1196P
Alpha Real Trust Limited
19 October 2012
 



19 October 2012

 

Alpha Real Trust Limited ("ART" or the "Company")

Proposed acquisition of the majority of the investments of Property Investment Portfolio Plc

Issue of new share class

 

Highlights

·; Proposed acquisition of the majority of the investments of Property Investment Portfolio Plc ("PIP") (and the "Investment Portfolio"), an unlisted open-ended investment company, on a NAV-for-NAV basis with consideration by way of a new unlisted class of ART A shares, subject to approval of a meeting of PIP shareholders to approve the sale of the Investment Portfolio to ART and approval by ART shareholders of a change in ART's Articles of Incorporation (the "Transaction").

·; PIP has a diversified exposure to the UK and European commercial property markets through a range of specialist fund investments.

·; The Investment Portfolio has a Net Asset Value ("NAV") at 30 June 2012 of £25.3 million. Post-acquisition, ART's total NAV would increase by 47%, and NAV per share would be unchanged save for transaction expenses.

·; The Directors believe the proposed acquisition of the Investment Portfolio will provide ART with the benefit of increased scale in addition to greater geographic diversification

·; The Board of ART states that its current intention is to declare an interim dividend of 1.05 pence per share. The declaration and payment of any dividend will be subject to completion of the acquisition of the Investment Portfolio and applicable Guernsey legislation. The interim dividend is expected to be paid during the first six months of 2013.

 

PIP Overview

PIP is an unlisted open-ended investment company incorporated in the Isle of Man which has a diversified exposure to the UK and European commercial property markets, as well as UK residential ground rents, through a range of specialist funds. PIP has been voluntarily suspended for dealing since January 2008.

PIP has a NAV of £26.4 million as at 30 June 2012, of which the majority is in 5 key investments:

·; £10.8 million investment in European Property Investment Portfolio Plc ("Europip"), a geared property fund principally invested in Norway

·; £4.6 million of Freehold Income Trust ("FIT") units, a fund invested in UK ground rents

·; £3.6 million in Healthcare & Leisure Property Limited ("HLP"), an ungeared leisure property fund

·; £3.3 million in Business Centre Properties Limited ("BCP"), a business centre fund which is predominantly ungeared

·; £0.5 million of Alpha UK Multi Property Trust Plc ("AUMP"), which is 19% of AUMP's ordinary share capital. AUMP has a regionally diversified portfolio of UK light industrial and office property.

PIP is managed by Alpha Real Property Investment Advisers LLP ("ARPIA"), a subsidiary of Alpha Real Capital LLP ("ARC"), the Investment Manager of ART.

Further detail on the investments can be found below.

 

Investment rationale

 

The Directors believe that the proposed acquisition of the Investment Portfolio will offer ART an opportunity to extend its investments in a number of areas both through additional exposure to existing ART investments and new investments which meet the Investing Policy of the Company.

ART is expected to benefit from the proposed acquisition of the Investment Portfolio for a number of reasons, including:

·; A scrip acquisition undertaken with ART A shares at NAV will allow the Company to grow without dilution to existing ART shareholders.

·; The Company´s enlarged portfolio will benefit from greater diversification by spread of investments.

·; The Transaction will provide ART geographic and currency diversification, including exposure to the Northern European market by way of a portfolio located in the strong Norwegian economy.

·; Certain assets within the Investment Portfolio offer scope for divestment over the medium term providing ART with the opportunity to recycle capital and target investments with scope for higher risk-adjusted returns. The increase in scale together with cash and liquid securities will allow the Company to potentially undertake larger individual investments in the future, increasing the range of available investment opportunities.

·; The nature, the diversification and quantum of earnings generated within the combinedinvestment portfolio is expected to enhance the ability of the Company to consider payment of a dividend. The current intention of the Board is to declare an interim dividend of 1.05 pence per share. The declaration and payment of any dividend will be subject to completion of the Transaction and applicable Guernsey legislation. The interim dividend is forecast to be paid during the first six months of 2013.

 

Transaction structure

 

Subject to class meetings of PIP shareholders to approve the sale of the Investment Portfolio to ART, and approval by ART shareholders of the creation of the new class of shares and amendments to the Articles of Incorporation, ART will issue a new class of unlisted A shares to PIP investors ("Class A Shares"). Meetings of PIP shareholders and ART shareholders are expected to take place by 20 November 2012. ART has ascribed zero value to PIP´s investment in Active Commercial Estates PLC ("ACE"), a fund invested in secondary commercial UK property and The Romulus High Income Trust ("Romulus"), a fund holding four UK business centres.

Any realised value from these investments will be passed to PIP shareholders by way of the ART Class A shares.

Based on the respective NAVs of ART and PIP, ART will issue 23,914,323 new Class A Shares to PIP in relation to the Transaction. PIP will subsequently distribute the ART Class A Shares to its shareholders. These Class A Shares will have the same rights as ART ordinary shares (save for the additional rights over ACE and Romulus proceeds), including the right to dividends, but will be unlisted. Holders have the option to convert their Class A Shares one-for-one into listed ART ordinary shares after a period of 60 days after issue of the shares.

To assist with any potential liquidity requirements, following completion of the Transaction the ART Board will consider the possibility of share buy-backs of up to 10% of the enlarged share capital of ART, subject to any necessary regulatory approvals.

 

Investment Portfolio being acquired

The Freehold Income Trust ("FIT") - 3% stake, equity value of £4.6 million

FIT, the open ended residential ground rent fund, delivered a total return for the 12 months to 31 March 2012 of 6.02%. This continues FIT's 19 year unbroken track record of positive, inflation beating returns. FIT was recently voted as having the best risk adjusted return of any fund in the IMA unit trust and OEIC universe over a 10 year period (FE Trustnet News and Research).

FIT's total gross assets at 30 June 2012 were £154.5 million. 75% of FIT's freeholds have a form of inflation protection through periodic uplifts linked to Retail Price Index, property values or fixed uplifts. FIT operates a monthly dealing facility to provide liquidity for investors and pays income distributions twice yearly in May and November. FIT exceeded its target annual income of 4.25% for its 2011/12 year with an income return of 5.32%.

European Property Investment Portfolio plc ("Europip") - 47% stake, equity value £6.4million, loan value £4.4million

Europip owns a portfolio of Norwegian commercial properties, an office building in Paris, and a minority investment in a central and eastern European commercial property fund, Mosaic Property C.E.E. Limited.

Europip has entered into a conditional contract for the sale of its Paris office property, the sale of which (scheduled for December 2012) may realise proceeds of approximately €2.0 million after the repayment of debt. It is anticipated that any proceeds would be applied to further reduce bank debt in Europip Norway, or alternatively may be available to return to the Company in whole or in part.

Healthcare & Leisure Property Limited ("HLP") - 13 minority stakes, equity value of £3.6million

HLP owns minority interests in a range of cinemas, pubs, hotels and leisure complexes in conjunction with other venture capital companies. HLP has no debt and continues to receive income from many of its investments while these interests are realised. 

Business Centre Properties Limited ("BCP") - 95% stake, equity value of £3.2million

BCP owns 5 business centres (serviced offices) in Bristol, Edinburgh, Reading and in Mitcham and Stratford in London.

Alpha UK Multi Property Trust plc ("AUMP") - 19% stake, equity value of £0.5m

PIP has a 19% stake in the ordinary shares of AUMP. These shares are valued at their open market value of the shares at 30 June 2012 of £0.33 per share as the shares of AUMP are listed on the London Stock Exchange.

The AUMP property portfolio comprises a well-diversified portfolio of 55 multi-let properties offering 528 leasable units with a total floor area of approximately 169,700 square metres (approximately 1.8 million square feet) all of which are located in the UK.

Active Commercial Estates PLC ("ACE") - equity value £0.8m (no consideration paid by ART)

PIP's investment in ACE is valued at 30 June 2012 at £0.8 million. ACE owns a portfolio of 22 secondary commercial properties across the UK.

The Romulus High Income Trust ("Romulus") - equity value £nil

Romulus has invested in 4 business centres (serviced offices) in Coventry, Clitheroe, Leeds and Mortlake in London.

ART is also acquiring net working capital of £2.6 million.

Any realised value from the ACE and Romulus investments will be passed to PIP shareholders by way of the ART Class A shares.

Other than HLP and Mosaic Property C.E.E. Limited, all of the above investments are managed by ARPIA or ARC.

 

 

Fair & Reasonable

ARC and ARPIA earn investment management fees from certain sub-funds within the Investment Portfolio. In accordance with ART's Investing Policy, ARC will reimburse ART an amount equivalent to the net fees that ARC would earn from ART's investment in these sub-funds.

The Directors of ART (excluding Phillip Rose) consider, having consulted with Panmure Gordon, that the terms of the Transaction and the fee rebate are fair and reasonable insofar as its shareholders are concerned. Phillip Rose is deemed to be a related party due to his relationship with ARC, and as such has not participated in the Board's consideration of the Transaction.

 

For further information please contact:

 

Alpha Real Trust Limited

David Jeffreys, Chairman, Alpha Real Trust Limited +44 (0) 1481 231 100

Brad Bauman, Joint Fund Manager, Alpha Real Trust Limited +44 (0) 20 7268 0300

 

Panmure Gordon, Broker to the Company

Richard Gray / Andrew Potts +44 (0) 20 7886 2500

 

About the Company

 

The Company is a closed-ended investment company incorporated in Guernsey that targets investment and development opportunities in real estate, including real estate operating companies, securities, services and other related businesses that offer high total returns.

Further information on the Company can be found on the Company's website:

www.alpharealtrustlimited.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAAENFDEAFFF
Date   Source Headline
1st May 20247:00 amRNSTotal Voting Rights
19th Apr 20242:34 pmRNSDirector/PDMR Shareholding
18th Apr 202411:16 amRNSDirector/PDMR Shareholding
16th Apr 202412:35 pmRNSDirector/PDMR Shareholding
16th Apr 202412:33 pmRNSDirector/PDMR Shareholding
16th Apr 202412:32 pmRNSDirector/PDMR Shareholding
5th Apr 20247:00 amRNSResults of Scrip Dividend Alternative Election
8th Mar 20248:52 amRNSSale of H20 Shopping Centre Investment, Madrid
1st Mar 20247:00 amRNSTrading Update and Dividend Announcement
13th Feb 20245:03 pmRNSDirector/PDMR Shareholding
1st Feb 202411:58 amRNSDirector/PDMR Shareholding
1st Feb 20247:00 amRNSTotal Voting Rights
31st Jan 202410:10 amRNSDirector/PDMR Shareholding
31st Jan 202410:10 amRNSDirector/PDMR Shareholding
31st Jan 202410:08 amRNSDirector/PDMR Shareholding
17th Jan 20247:00 amRNSResults of Scrip Dividend Alternative Election
15th Dec 20231:30 pmRNSHalf-year Report
6th Dec 20232:47 pmRNSDirector/PDMR Shareholding
27th Nov 20231:16 pmRNSDirector/PDMR Shareholding
24th Nov 20237:00 amRNSHalf-year Report
1st Nov 20237:00 amRNSTotal Voting Rights
31st Oct 20236:00 pmRNSDirector/PDMR Shareholding
31st Oct 20235:55 pmRNSDirector/PDMR Shareholding
31st Oct 20235:52 pmRNSDirector/PDMR Shareholding
25th Oct 20239:02 amRNSDirector/PDMR Shareholding
23rd Oct 20237:00 amRNSResults of Scrip Dividend Alternative Selection
26th Sep 20234:39 pmRNSDirector/PDMR Shareholding
20th Sep 20235:37 pmRNSDirector/PDMR Shareholding
15th Sep 20237:00 amRNSTrading Statement and Dividend Announcement
7th Sep 202312:04 pmRNSResult of AGM
25th Aug 20234:50 pmRNSAcquisition of a Travelodge Hotel in Yardley, UK
11th Aug 202312:51 pmRNSDirector/PDMR Shareholding
7th Aug 202310:24 amRNSDirector/PDMR Shareholding
7th Aug 202310:22 amRNSDirector/PDMR Shareholding
7th Aug 202310:17 amRNSDirector/PDMR Shareholding
1st Aug 20237:00 amRNSTotal Voting Rights
24th Jul 20237:00 amRNSResults of Scrip Dividend Alternative Election
7th Jul 20234:13 pmRNSAnnual Financial Report
23rd Jun 20237:00 amRNSAnnual Results for the year ended 31.3.23
2nd May 20237:00 amRNSTotal Voting Rights
18th Apr 20233:08 pmRNSDirector/PDMR Shareholding
11th Apr 20232:29 pmRNSDirector/PDMR Shareholding
11th Apr 20232:28 pmRNSDirector/PDMR Shareholding
6th Apr 20237:00 amRNSDirector/PDMR Shareholding
5th Apr 20239:47 amRNSDirector/PDMR Shareholding
30th Mar 202310:35 amRNSResults of Scrip Dividend Alternative Election
27th Mar 20234:03 pmRNSDirector/PDMR Shareholding
24th Mar 20239:47 amRNSDirector/PDMR Shareholding
1st Mar 202311:57 amRNSDirector/PDMR Shareholding
24th Feb 20237:00 amRNSTrading Update and Dividend Announcement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.